Related Experiment Video
Updated: May 14, 2026

07:30
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
[Liquid ecstasy in general psychiatry: a case series]
R W Freudenmann1, E Baumgarten, A E Hawlik
1Klinik für Psychiatrie und Psychotherapie III, Universitätsklinikum Ulm, Germany. roland.freudenmann@uni-ulm.de
Fortschritte Der Neurologie-Psychiatrie
|February 16, 2013
Summary
Liquid ecstasy (LE), including GHB and GBL, causes severe withdrawal in psychiatric patients. Early recognition and benzodiazepine treatment are crucial for managing LE withdrawal, even in low-prevalence cases.
Area of Science:
- Psychiatry and Addiction Medicine
- Pharmacology and Toxicology
Context:
- Liquid ecstasy (LE), encompassing GHB, GBL, and 1,4-B, is recognized for severe intoxications in emergency medicine but is less understood in general psychiatry.
- This study addresses the under-recognized role of LE in general psychiatric settings, focusing on user demographics and clinical challenges.
Purpose:
- To investigate the prevalence, characteristics, and clinical management of patients using liquid ecstasy (LE) within a general psychiatry department.
- To identify typical users, common clinical problems, and effective treatment strategies for LE intoxication and withdrawal.
Summary:
- A retrospective study identified 19 LE users over 14 years, predominantly young men with polysubstance abuse, with GBL being the most common form.
- Severe and sudden withdrawal symptoms necessitated intermediate care for a third of patients, highlighting LE withdrawal as a significant clinical issue.
- Detoxification in psychiatry was achievable with high-dose benzodiazepines, and three patients met criteria for GBL dependence.
Impact:
- This research underscores the importance of considering LE use and withdrawal in cases of unexplained coma or delirium, prompting closer collaboration between psychiatry and intermediate care units.
- The findings emphasize that while LE prevalence in psychiatry is low, the severity of withdrawal necessitates clinical awareness and preparedness.
- The difficulty in detecting LE in routine screenings poses diagnostic challenges, reinforcing the need for clinical suspicion and targeted management strategies.
Related Concept Videos
CNS Stimulants: Psychedelic Agents
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Hallucinogens and Psychedelics
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Toxidromes: Clinical Features
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
